First application of the EBMT risk score in double umbilical cord blood transplantation for hematologic malignancies: Significant impact on different outcomes

Experimental Hematology

Volumn 42, Issue 3, 2014, Pages 161-162

  Wallet, Hélène Labussière ^a   Sobh, Mohamad ^a   Robin, Marie ^b   Fegueux, Nathalie ^c   Fürst, Sabine ^d   Mohty, Mohamad ^e   Yakoub Agha, Ibrahim ^f   Marry, Evelyne ^g   Rocha, Vanderson ^b,h   Blaise, Didier ^d   Milpied, Noël ⁱ   Nicolini, Franck Emmanuel ^a   Michallet, Mauricette ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c LAPEYRONIE HOSPITAL   (France)

^d INSTITUT PAOLI CALMETTES   (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g Agence de la Biomedecine   (France)

^h EUROCORD   (France)

ⁱ UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CORD BLOOD STEM CELL TRANSPLANTATION; EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION; GENE FREQUENCY; HEMATOLOGIC MALIGNANCY; HLA TYPING; HODGKIN DISEASE; HUMAN; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RISK ASSESSMENT; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; EUROPE; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84897776005     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2013.11.007     Document Type: Article

References (3)

1. Gratwohl A., Hermans J., Goldman J.M., et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 1998, 352:1087-1092.
2. Wallet H.L., Sobh M., Morisset S., et al. Double umbilical cord blood transplantation for hematological malignancies: A long-term analysis from the SFGM-TC registry. Exp Hematol 2013, 41:924-933.
3. Sorror M.L., Maris M.B., Storb R., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005, 106:2912-2919.